FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and aims at preserving the balance of healthy microflora in the urogenital area of the patient. Composition for local administration to maintain the balance of healthy microflora in the urogenital area of the patient in need thereof contains a first therapeutic agent consisting of pentose or disaccharide, and a second therapeutic agent selected from a group consisting of a non-digestible polysaccharide, an organic acid, cyclodextrin, pectin substance, pentose and disaccharide. Another alternative embodiment of the composition for local administration for maintaining the balance of healthy microflora in the urogenital area of the patient in need thereof includes a first therapeutic agent consisting of cyclodextrin or pectin substance, and a second therapeutic agent selected from the group consisting of pectin substance, pentose, disaccharide and non-digestible polysaccharide. In all embodiments, the first therapeutic agent and the second therapeutic agent are different, wherein the total concentration of the therapeutic agents is less than 10.0 wt./vol. %. Another embodiment is a method of maintaining a balance of healthy microflora in the urogenital area of the patient, comprising a local introduction into the urogenital area of the patient of a composition containing a first therapeutic agent consisting of pentose or disaccharide, and a second therapeutic agent selected from a group consisting of a non-digestible polysaccharide, an organic acid, cyclodextrin, pectin substance, pentose or disaccharide, where the first therapeutic agent and the second therapeutic agent are different.
EFFECT: using the invention provides maintaining and retaining the balance of the healthy microflora in the urogenital area of the patient.
15 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR MAINTENANCE OF LACTOBACTERIA DOMINATION | 2015 |
|
RU2723015C2 |
SYNERGIC COMPOSITION TO MAINTAIN HEALTHY BALANCE OF MICROFLORA | 2017 |
|
RU2748651C2 |
BENDAMUSTINE AND CYCLOPOLISACCHARIDE COMPOSITION | 2011 |
|
RU2647368C2 |
COMPOSITIONS AND METHODS OF PREVENTING OR TREATING URINARY INCONTINENCE, BLADDER OVERACTIVITY OR MENSTRUAL CRAMPS | 2019 |
|
RU2808470C2 |
PERITONEAL THERAPEUTIC LIQUID | 2016 |
|
RU2718908C2 |
BENDAMUSTINE AND CYCLOPOLYSACCHARIDE COMPOSITIONS | 2010 |
|
RU2734236C2 |
AGENT FOR INTRAVAGINAL DELIVERY OF ACTIVE COMPONENT, METHOD OF PRODUCTION AND USE OF THE MEDICINAL PRODUCT | 2022 |
|
RU2806114C2 |
PREBIOTIC-BASED COMPOSITIONS AND METHODS FOR MAINTAINING HEALTHY SKIN MICROBIOTA | 2019 |
|
RU2792104C2 |
PHARMACEUTICAL COMPOSITION CONTAINING TETRAHYDROFOLIC ACID | 2007 |
|
RU2479306C2 |
IONIC MOLECULAR CONJUGATES OF N-ACYLATED DERIVATIVES OF POLY-(2-AMINO-2-DEOXY-D- GLUCOSE) AND POLYPEPTIDES | 1996 |
|
RU2172323C2 |
Authors
Dates
2019-12-18—Published
2015-09-29—Filed